Protalix BioTherapeutics set to join Russell 3000® Index

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization...

Related Keywords

United States ,Carmiel ,Ha Afon ,Israel ,Brazil ,London ,City Of ,United Kingdom ,American ,Chuck Padala ,Chiesi Farmaceutici ,Dror Bashan ,Pfizer Inc ,Prnewswire Protalix Biotherapeutics Inc ,Protalix Biotherapeutics Inc ,European Union ,European Medicines Agency ,Drug Administration ,Exchange Commission ,London Stock Exchange Group ,Chief Executive ,London Stock Exchange ,Private Securities Litigation Reform Act ,Protalix Biotherapeutics ,Nc ,